The Aloxi Patient Assistance Program (PAP) is no longer accepting new applications for assistance. If you are a patient, please contact your physician to discuss treatment options including lower-cost alternatives and other currently available patient support resources.
Any patients currently enrolled in the Aloxi Patient Assistance Program may remain on PAP through April 1, 2019, provided they continue to meet Program eligibility criteria.
If you have questions about your previously-submitted application please contact:
Phone: 1-866-61-EISAI (1-866-613-4724)
Monday – Friday, 8am – 8pm ET
These foundations offer financial and other assistance (education, counseling, support groups, etc.) to patients.
Eisai cannot guarantee payment of any claim. Coding, coverage, and reimbursement may vary significantly by payor, plan, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payors following the receipt of claims. For additional information, customers should consult with their payors for all relevant coding, reimbursement, and coverage requirements. It is the sole responsibility of the provider to select the proper code and ensure the accuracy of all claims used in seeking reimbursement. All services must be medically appropriate and properly supported in the patient medical record.
ALOXI® injection is used in adults to help prevent nausea and vomiting on the day of chemotherapy that is highly likely to cause nausea and vomiting, and up to 5 days following chemotherapy that is moderately likely to cause nausea and vomiting.
ALOXI® injection is used in children 1 month old to less than 17 years of age to help prevent nausea and vomiting on the day of chemotherapy that is moderately or highly likely to cause nausea and vomiting.
For more information about ALOXI®, talk to your doctor or see full Prescribing Information.
ALOXI® is available by prescription only.